Cellectar Biosciences, Inc. (CLRB)
3.17
0.00 (0.00%)
USD |
NASDAQ |
May 21, 16:00
3.14
-0.03
(-0.95%)
After-Hours: 19:59
Cellectar Biosciences Research and Development Expense (TTM) : 11.08M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Karyopharm Therapeutics, Inc. | 124.57M |
| Ocugen, Inc. | 39.60M |
| Invivyd, Inc. | 58.40M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |